174 related articles for article (PubMed ID: 17523695)
21. Pharmacogenetics of acute lymphoblastic leukemia.
Mehta PA; Davies SM
Curr Opin Hematol; 2004 Nov; 11(6):434-8. PubMed ID: 15548999
[TBL] [Abstract][Full Text] [Related]
22. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
[TBL] [Abstract][Full Text] [Related]
23. The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure.
Beesley AH; Cummings AJ; Freitas JR; Hoffmann K; Firth MJ; Ford J; de Klerk NH; Kees UR
Br J Haematol; 2005 Nov; 131(4):447-56. PubMed ID: 16281934
[TBL] [Abstract][Full Text] [Related]
24. Advances in acute lymphoblastic leukemia.
Randolph TR
Clin Lab Sci; 2004; 17(4):235-45. PubMed ID: 15559730
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.
Andersson A; Edén P; Lindgren D; Nilsson J; Lassen C; Heldrup J; Fontes M; Borg A; Mitelman F; Johansson B; Höglund M; Fioretos T
Leukemia; 2005 Jun; 19(6):1042-50. PubMed ID: 15843827
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiles in a panel of childhood leukemia cell lines mirror critical features of the disease.
Kees UR; Ford J; Watson M; Murch A; Ringńer M; Walker RL; Meltzer P
Mol Cancer Ther; 2003 Jul; 2(7):671-7. PubMed ID: 12883040
[TBL] [Abstract][Full Text] [Related]
27. Prediction of relapse in paediatric pre-B acute lymphoblastic leukaemia using a three-gene risk index.
Hoffmann K; Firth MJ; Beesley AH; Freitas JR; Ford J; Senanayake S; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2008 Mar; 140(6):656-64. PubMed ID: 18302714
[TBL] [Abstract][Full Text] [Related]
28. [Preliminary study of gene expression profile associated with risk classification of childhood patients with acute lymphoblastic leukemia].
Wang JL; Chai YH; Ji ZH; Shao XJ; Huang YP
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):29-33. PubMed ID: 21429398
[TBL] [Abstract][Full Text] [Related]
29. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
30. The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes.
Talby L; Chambost H; Roubaud MC; N'Guyen C; Milili M; Loriod B; Fossat C; Picard C; Gabert J; Chiappetta P; Michel G; Schiff C
Leuk Res; 2006 Jun; 30(6):665-76. PubMed ID: 16297978
[TBL] [Abstract][Full Text] [Related]
31. New mechanisms of resistance in Philadelphia chromosome acute lymphoblastic leukemia.
Martinelli G; Iacobucci I; Soverini S; Piccaluga PP; Cilloni D; Pane F
Expert Rev Hematol; 2009 Jun; 2(3):297-303. PubMed ID: 21082971
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of gene expression profiling of acute myeloid leukemia.
Mills KI; Gilkes AF
Curr Hematol Malig Rep; 2006 Jun; 1(2):114-21. PubMed ID: 20425341
[TBL] [Abstract][Full Text] [Related]
33. Genomic profiling of high-risk acute lymphoblastic leukemia.
Collins-Underwood JR; Mullighan CG
Leukemia; 2010 Oct; 24(10):1676-85. PubMed ID: 20739952
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of rs62527607 [GT] single nucleotide polymorphism located in BAALC gene in children with acute leukemia using mismatch PCR-RFLP.
Nadimi M; Rahgozar S; Moafi A; Tavassoli M; Mesrian Tanha H
Cancer Genet; 2016; 209(7-8):348-53. PubMed ID: 27372260
[TBL] [Abstract][Full Text] [Related]
35. Genomic assessment of pediatric acute leukemia.
Mullighan CG; Flotho C; Downing JR
Cancer J; 2005; 11(4):268-82. PubMed ID: 16197717
[TBL] [Abstract][Full Text] [Related]
36. Current status of gene expression profiling in the diagnosis and management of acute leukaemia.
Bacher U; Kohlmann A; Haferlach T
Br J Haematol; 2009 Jun; 145(5):555-68. PubMed ID: 19344393
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
Gottardo NG; Hoffmann K; Beesley AH; Freitas JR; Firth MJ; Perera KU; de Klerk NH; Baker DL; Kees UR
Br J Haematol; 2007 May; 137(4):319-28. PubMed ID: 17456054
[TBL] [Abstract][Full Text] [Related]
38. Building better therapy for children with acute lymphoblastic leukemia.
Carroll WL; Raetz EA
Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
[TBL] [Abstract][Full Text] [Related]
39. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
Laskowska J; Lewandowska-Bieniek J; Szczepanek J; Styczyński J; Tretyn A
J Gene Med; 2016 Aug; 18(8):165-79. PubMed ID: 27280600
[TBL] [Abstract][Full Text] [Related]
40. How new advances in genetic analysis are influencing the understanding and treatment of childhood acute leukemia.
Roberts KG; Mullighan CG
Curr Opin Pediatr; 2011 Feb; 23(1):34-40. PubMed ID: 21169835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
